المؤلفون: Dimakakos, Evangelos, Gomatou, Georgia, Catalano, Mariella, Olinic, Dan-Mircea, Spyropoulos, Alex C, Falanga, Anna, Maraveyas, Anthony, Liew, Aaron, Schulman, Sam, Belch, Jill, Gerotziafas, Grigorios, Marschang, Peter, Cosmi, Benilde, Spaak, Jonas, Syrigos, Konstantinos

المساهمون: Gottsäter, Anders, Creator

المصدر: Anticancer research EpiHealth: Epidemiology for Health. 42(7):3261-3274

مصطلحات موضوعية: Anticoagulants/therapeutic use, COVID-19/complications, Endothelial Cells, Heparin, Low-Molecular-Weight/therapeutic use, Humans, Neoplasms/complications, Prospective Studies, RNA, Viral, Risk Factors, SARS-CoV-2, Thrombosis/drug therapy, Venous Thromboembolism/drug therapy, Medicin och hälsovetenskap, Klinisk medicin, Kardiologi, Medical and Health Sciences, Clinical Medicine, Cardiac and Cardiovascular Systems

URL الوصول: https://lup.lub.lu.se/record/872fd14a-8be0-4f5c-80ad-9148e0dc0446
http://dx.doi.org/10.21873/anticanres.15815

المؤلفون: Bradbury, Charlotte A., Lawler, Patrick R., Stanworth, Simon J., McVerry, Bryan J., McQuilten, Zoe, Higgins, Alisa M., Mouncey, Paul R., Al-Beidh, Farah, Rowan, Kathryn M., Berry, Lindsay R., Lorenzi, Elizabeth, Zarychanski, Ryan, Arabi, Yaseen M., Annane, Djillali, Beane, Abi, Van Bentum-Puijk, Wilma, Bhimani, Zahra, Bihari, Shailesh, Bonten, Marc J. M., Brunkhorst, Frank M., Buzgau, Adrian, Buxton, Meredith, Carrier, Marc, Cheng, Allen C., Cove, Matthew, Detry, Michelle A., Estcourt, Lise J., Fitzgerald, Mark, Girard, Timothy D., Goligher, Ewan C., Goossens, Herman, Haniffa, Rashan, Hills, Thomas, Huang, David T., Horvat, Christopher M., Hunt, Beverley J., Ichihara, Nao, Lamontagne, Francois, Leavis, Helen L., Linstrum, Kelsey M., Litton, Edward, Marshall, John C., McAuley, Daniel F., McGlothlin, Anna, McGuinness, Shay P., Middeldorp, Saskia, Montgomery, Stephanie K., Morpeth, Susan C., Murthy, Srinivas, Neal, Matthew D., Nichol, Alistair D., Parke, Rachael L., Parker, Jane C., Reyes, Luis, Saito, Hiroki, Santos, Marlene S., Saunders, Christina T., Serpa-Neto, Ary, Seymour, Christopher W., Shankar-Hari, Manu, Singh, Vanessa, Tolppa, Timo, Turgeon, Alexis F., Turner, Anne M., van de Veerdonk, Frank L., Green, Cameron, Lewis, Roger J., Angus, Derek C., McArthur, Colin J., Berry, Scott, Derde, Lennie P. G., Webb, Steve A., Gordon, Anthony C., Depuydt, Pieter, De Waele, Jan, De Bus, Liesbet, Fierens, Jan, Vermassen, Joris

المساهمون: REMAP-CAP Investigators, University of Bristol [Bristol], University Health Network, University of Toronto, University of Oxford, University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE), Monash University [Melbourne], Imperial College London, University of Manitoba [Winnipeg], Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), University Medical Center [Utrecht], St. Michael's Hospital, 215522, CS-2016-16-011, RP-2015-06-18, National Institutes of Health, NIH, U.S. Department of Defense, DOD, National Institute of General Medical Sciences, NIGMS, National Institute of Neurological Disorders and Stroke, NINDS, Gordon and Betty Moore Foundation, GBMF, Medtronic, Baxter International, Medical Center, University of Pittsburgh, CancerCare Manitoba Foundation, CCMF, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, Wellcome Trust, WT, Health Research Board, HRB: CTN 2014-012, Horizon 2020 Framework Programme, H2020: 101003589, LAM Therapeutics, Canadian Institutes of Health Research, IRSC: 158584, Medical Research Council, MRC, National Institute for Health and Care Research, NIHR, European Commission, EC, National Heart and Lung Institute, NHLI, Queen's University Belfast, QUB: US8962032, National Health and Medical Research Council, NHMRC: APP1101719, National Medical Research Council, NMRC, Health Research Council of New Zealand, HRC: 16/631, Ministère des Affaires Sociales et de la Santé: PHRC-20-0147, Innovate UK, Horizon 2020, Pharmaceuticals Bayer, Swedish Orphan Biovitrum, NIHR Imperial Biomedical Research Centre, BRC, Minderoo Foundation, Funding/Support: This study was funded by the following: the Platform for European Preparedness Against (Re-)Emerging Epidemics (PREPARE) consortium of the European Union, FP7-HEALTH-2013-INNOVATION-1 (grant 602525), the Rapid European COVID-19 Emergency Research Response (RECOVER) consortium of the European Union’s Horizon 2020 Research and Innovation Programme (grant 101003589), the Australian National Health and Medical Research Council (grant APP1101719), the Health Research Council of New Zealand (grant 16/631), the Canadian Institute of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program (grant 158584), the NIHR and the NIHR Imperial Biomedical Research Centre, the Health Research Board of Ireland (grant CTN 2014-012), the University of Pittsburgh Medical Center (UPMC) Learning While Doing Program, the Translational Breast Cancer Research Consortium, the French Ministry of Health (grant PHRC-20-0147), the Minderoo Foundation, and the Wellcome Trust Innovations Project (grant 215522). Dr Shankar-Hari is funded by an NIHR clinician scientist fellowship (grant CS-2016-16-011) and Dr Gordon is funded by an NIHR research professorship (grant RP-2015-06-18)., The REMAP-CAP platform is supported by the Australian and New Zealand Intensive Care Society Clinical Trials Group, the Canadian Critical Care Clinical Trials Group, the Irish Critical Care Clinical Trials Network, the UK Critical Care Research Group and the International Forum of Acute Care Trialists., REMAP-CAP was supported in the Netherlands by the Research Collaboration Critical Care the Netherlands, reported receipt of personal fees from Lilly, BMS-Pfizer, Bayer, Amgen, Novartis, Janssen, Portola, Ablynx, and Grifols. Dr Lawler reported receipt of personal fees from Novartis, CorEvitas, and Brigham and Women’s Hospital and royalties from McGraw-Hill Publishing. Dr McVerry reported receipt of grants from the National Heart, Lung, and Blood Institute and Bayer Pharmaceuticals and personal fees from Boehringer Ingelheim. Dr L. Berry reported being an employee of Berry Consultants, Berry Consultants receives payments for the statistical analysis and design of REMAP-CAP. Dr Lorenzi reported being an employee of Berry Consultants, Berry Consultants receives payments for the statistical analysis and design of REMAP-CAP. Dr Zarychanski reported receipt of grants from the Canadian Institutes of Health Research, LifeArc, Research Manitoba, the CancerCare Manitoba Foundation, Peter Munk Cardiac Centre, and the Thistledown Foundation and research operating support as the Lyonel G. Israels Research Chair in Hematology. Dr Bonten reported membership in international study steering committees, advisory boards, and independent data safety and monitoring committees funded by Janssen Vaccines, Merck Sharp & Dohme, AstraZeneca, Pfizer, and Sanofi Pasteur (all reimbursements to UMC Utrecht). Dr Brunkhorst reported receipt of grants from Jena University Hospital. Dr Buxton reported receipt of a gift from the Breast Cancer Research Foundation and contracts with Amgen and Eisai. Dr Carrier reported receipt of grants from BMS-Pfizer and personal fees from Bayer, Sanofi, Servier, Leo Phama, and BMS-Pfizer to his institution. Dr Cove reported receipt of grants from the National Medical Research Council and personal fees from Baxter and Medtronic. Dr Estcourt reported receipt of grants from the UK National Institute for Health Research (NIHR) and the European Union Horizon 2020 Research and Innovation Programme. Dr Haniffa reported receipt of grants from the UK Research and Innovation/Medical Research Council African Critical Care Registry Network. Dr Horvat reported receipt of grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Dr Ichihara reported being affiliated with the Department of Healthcare Quality Assessment, University of Tokyo, which is a social collaboration supported by the National Clinical Database, Johnson & Johnson, and Nipro Corporation. Dr Marshall reported receipt of personal fees from AM Pharma and Critical Care Medicine. Dr McAuley reported receipt of personal fees from Bayer, GlaxoSmithKline, Boehringer Ingelheim, Novartis, Lilly, Vir Biotechnology, Faron Pharmaceutical, and SOBI and grants from the NIHR, the Wellcome Trust, Innovate UK, the UK Medical Research Council, and the Northern Ireland Health and Social Care Research and Development Division, in addition, Dr McAuley had a Queen’s University Belfast patent for novel treatment for inflammatory disease (US8962032), was co-director of research at the Intensive Care Society until June 2021, and was director of the Efficacy and Mechanisms Evaluation Program for the UK Medical Research Council/NIHR. Dr Middeldorp reported receipt of personal fees from Daiichi Sankyo, Bayer, Pfizer, Boehringer Ingelheim, Portola/Alexion, AbbVie, BMS-Pfizer, Sanofi, and Viatris, all paid to his institution, and grants from Daiichi Sankyo, Bayer, Pfizer, and Boehringer Ingelheim. Dr Neal reported equity in Haima Therapeutics, receipt of personal fees from Janssen Pharma and Haemonetics, and receipt of grants from Instrumentation Laboratory, the National Institutes of Health, and the Department of Defense. Dr Nichol reported receipt of personal fees from AM Pharma, paid to his university, and grants from Baxter. Dr Parke reported receipt of grants from Fisher and Paykel Healthcare NZ. Dr Serpa-Neto reported receipt of personal fees from Drager and Endpoint Health. Dr Seymour reported receipt of grants from the Gordon and Betty Moore Foundation and the National Institutes of Health/National Institute of General Medical Sciences. Dr Lewis reported being senior medical scientist at Berry Consultants, Berry Consultants receives payments for the statistical analysis and design of REMAP-CAP. Dr S. Berry reported being an employee with an ownership role at Berry Consultants, Berry Consultants receives payments for the statistical analysis and design of REMAP-CAP. Dr Derde reported being a coordinating committee member for the European Clinical Research Alliance on Infectious Diseases, a member of the Dutch Intensivists Task Force on Acute Infectious Threats, a member of the International Scientific Advisory Board for Sepsis Canada, and a member of the Dutch Academy of Sciences’ Pandemic Preparedness Plan committee. Dr Gordon reported receipt of personal fees from 30 Respiratory, paid to his institution. No other disclosures were reported., European Project: 101003589, H2020-SC1-PHE-CORONAVIRUS-2020,RECOVER(2020), European Project: 602525,EC:FP7:HEALTH,FP7-HEALTH-2013-INNOVATION-1,PREPARE(2014), Investigators, REMAP-CAP Writing Committee for the REMAP-CAP, Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, ARD - Amsterdam Reproduction and Development, Intensive Care Medicine

المصدر: Jama : Journal of the American Medical Association, 327, 1247-1259
JAMA : the journal of the American Medical Association
Journal of the American Medical Association
Journal of the American Medical Association, 2022, 327 (13), pp.1247-1259. ⟨10.1001/jama.2022.2910⟩
2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 : A Randomized Clinical Trial ', JAMA-Journal of the American Medical Association, vol. 327, no. 13, 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Jama : Journal of the American Medical Association, 327, 13, pp. 1247-1259
2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 : A Randomized Clinical Trial ', Journal of the American Medical Association, vol. 327, no. 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
Investigators, REMAP-CAP W C F T REMAP-CAP & Dark, P 2022, ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. ', JAMA, vol. 327, no. 13, pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910
JAMA-Journal of the American Medical Association, 327(13), 1247-1259. American Medical Association

مصطلحات موضوعية: Adult, Male, Platelet Aggregation Inhibitors/adverse effects, Critical Illness, [SDV]Life Sciences [q-bio], Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], Hemorrhage, Aspirin/adverse effects, Hemorrhage/chemically induced, INFECTION, Humans, COAGULOPATHY, Aspirin, Anticoagulants, COVID-19, Bayes Theorem, Venous Thromboembolism, General Medicine, Middle Aged, Respiration, Artificial, COVID-19 Drug Treatment, Critical Illness/mortality, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists, COVID-19/complications, Female, Human medicine, Anticoagulants/adverse effects, Platelet Aggregation Inhibitors, Venous Thromboembolism/drug therapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd97581539d83269af5e1bb53f2dc11b
http://www.scopus.com/inward/record.url?scp=85127571047&partnerID=8YFLogxK

المؤلفون: Petra Bistrovic, Anica Sabljic, Ivona Kovacevic, Tomislav Cikara, Tatjana Keres, Tomo Lucijanic, Josko Mitrovic, Diana Delic-Brkljacic, Sime Manola, Marko Lucijanic

مصطلحات موضوعية: Anticoagulants / adverse effects, Male, Venous Thromboembolism / drug therapy, Warfarin / adverse effects, Anticoagulant therapy, Bleeding, SARS-CoV-2, Survival, Thrombosis, Administration, Oral, COVID-19, Humans, Female, Cardiology and Cardiovascular Medicine, Aged, Retrospective Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b438a24431e8fa1d030b453774d4df6
https://doi.org/10.1016/j.ijcard.2022.11.051

المؤلفون: Ingrid M. Bistervels, Hanke M.G. Wiegers, Fionnuala Ní Áinle, Suzanne M. Bleker, Céline Chauleur, Jennifer Donnelly, Anne F. Jacobsen, Marc A. Rodger, Maria T. DeSancho, Peter Verhamme, Anette T. Hansen, Roman G. Shmakov, Wessel Ganzevoort, Andrea Buchmüller, Saskia Middeldorp

المساهمون: Graduate School, Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, Amsterdam Reproduction & Development (AR&D), Amsterdam Cardiovascular Sciences, Obstetrics and Gynaecology, APH - Quality of Care

المصدر: Journal of Thrombosis and Haemostasis, 21, 57-67
Bistervels, I M, Wiegers, H M G, Áinle, F N, Bleker, S M, Chauleur, C, Donnelly, J, Jacobsen, A F, Rodger, M A, DeSancho, M T, Verhamme, P, Hansen, A T, Shmakov, R G, Ganzevoort, W, Buchmüller, A, Middeldorp, S & Highlow Investigators 2023, ' Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin : insights from the Highlow study ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 57-67 . https://doi.org/10.1016/j.jtha.2022.11.004
Journal of Thrombosis and Haemostasis, 21, 1, pp. 57-67
Journal of thrombosis and haemostasis : JTH, 21(1), 57-67. Wiley-Blackwell

مصطلحات موضوعية: Male, anesthesia and analgesia, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], venous thromboembolism, labor, Hematology, heparin, All institutes and research themes of the Radboud University Medical Center, Anticoagulants/therapeutic use, Heparin, Low-Molecular-Weight/therapeutic use, Pregnancy, low-molecular-weight, obstetric, Humans, Female, pregnancy, Analgesia, Venous Thromboembolism/drug therapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3654d189dac1bc9406534275cd70541
http://hdl.handle.net/2066/290874

المؤلفون: Ingrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, Fionnuala Ní Áinle, Bernard Tardy, Jennifer Donnelly, Peter Verhamme, Anne F Jacobsen, Anette T Hansen, Marc A Rodger, Maria T DeSancho, Roman G Shmakov, Nick van Es, Martin H Prins, Céline Chauleur, Saskia Middeldorp, Eline S van den Akker, Mireille N Bekker, Thomas van Bemmel, Laurent Bertoletti, Julie Blanc, Suzanne M Bleker, Aude Bourtembourg-Matras, Florence Bretelle, Bridgette Byrne, Francis Couturaud, Pierre Delorme, Elise S Eerenberg, Maureen TM Franssen, Jens Fuglsang, Wessel Ganzevoort, François Goffinet, Jiska M de Haan-Jebbink, Wieteke Heidema, Monique A Hertzberg, Marcel MC Hovens, Menno V Huisman, Leonie de Jong-Speksnijder, Pieter-Willem Kamphuisen, Denis J O'Keeffe, Karine Lacut, Josje Langenveld, M Simone Lunshof, Caroline P Martens, Adel Merah, Emmanuelle Le Moigne, Dimitri NM Papatsonis, Gilles Pernod, Franck Perrotin, Edith Peynaud-Debayle, Fabrice Pierre, Geneviève Plu Bureau, Tiphaine Raia-Barjat, Robbert JP Rijnders, Roger Rosario, Marc Ruivard, Jeannot Schmidt, Marieke Sueters, Thomas Vanassche, Marie-Noëlle Varlet, Alexandre J Vivanti, Matthieu Y van der Vlist, Lucet F van der Voet, Karlijn C Vollebregt, Johanna IP de Vries, Sabina de Weerd, Peter E Westerweel, Lia DE Wijnberger, Marije ten Wolde, Paula F Ypma, Catherine Zuily-Lamy, Joost J Zwart, Alexandra Benachi, Gaël Beucher, Holy Bezanahary, Karin de Boer, Marjon A. de Boer, Frantz Bousquet, Henk A. Bremer, Luc Bressollette, Aurélie Brossard, Cécile Chau, Brian Cleary, Fabienne Comte, Thomas Corsini, Anne Coustel, Barbara Debaveye, Raoul Desbrière, Cécile Duvillard, Astrid Eckman, Jeroen Eikenboom, Antoine Elias, Laura M. Faber, Emile Ferrari, Denis Gallot, Emilie Gauchotte, Ingrid Gaugler, Abby E. Geerlings, Audrey O'Gorman, Vincent Grobost, Pieter-Kees de Groot, David P. van der Ham, Brenda Hermsen, Kim Kamphorst, Alan Karovitch, Gunilla Kleiverda, Aiste Kloster, Annemarieke Koops, Inneke Krabbendam, Marieke J.H.A. Kruip, Saskia Kuipers, Judith van Laar, Damien Laneelle, Suzanne Lima, Peter MacMahon, Laurent Mandelbrot, Claudia A. van Meir, Caroline Menez, Leonard P. Morssink, Nathalie Moulin, Eve Mousty, Matthieu Muller, Lucy Murphy, Kathelijne Peerlinck, Alma O'Reilly, Maartje de Reus, Magali Hilmi Le Roux, Kevin Ryan, Bettina Samren, Daniela Schippers, Nico Schuitemaker, Chloé Schweizer, Hanneke van der Straaten, Cécile Tromeur, Kristine Vanheule, Tamara Verhagen, Jantien Visser, Michael Watts, Wim J. van Wijngaarden, Mallory Woiski, Maartje Zelis

المساهمون: Obstetrics and gynaecology, AMS - Rehabilitation & Development, Amsterdam Reproduction & Development (AR&D), VU University medical center, Cardiology, ACS - Heart failure & arrhythmias, Graduate School, Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, ARD - Amsterdam Reproduction and Development, ACS - Amsterdam Cardiovascular Sciences, CCA -Cancer Center Amsterdam, Obstetrics and Gynaecology, APH - Quality of Care, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, APH - Digital Health, ACS - Atherosclerosis & ischemic syndromes, RS: CAPHRI - R5 - Optimising Patient Care, MUMC+: KIO Kemta (9), Surgery, Public Health, Obstetrics & Gynecology, Hematology, Epidemiology

المصدر: The Lancet, 400(10365), 1777-1787. Elsevier Limited
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787

مصطلحات موضوعية: Low-Molecular-Weight/adverse effects, Male, Heparin, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Postpartum Period, Postpartum Hemorrhage, Heparin, Low-Molecular-Weight/adverse effects, Obstetrics and Gynecology, Anticoagulants, General Medicine, Venous Thromboembolism, Heparin, Low-Molecular-Weight, Pregnancy, Humans, Pulmonary Embolism/prevention & control, Female, Anticoagulants/adverse effects, Pulmonary Embolism, Venous Thromboembolism/drug therapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8643920b0d7863c0bf84cfcc765abbb7
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9

المؤلفون: Winckers, Kristien, Ten Cate, Hugo

المساهمون: Biochemie, MUMC+: MA Alg Interne Geneeskunde (9), Interne Geneeskunde, RS: Carim - B04 Clinical thrombosis and Haemostasis

المصدر: Nederlands Tijdschrift voor Geneeskunde, 166:D6882. Bohn Stafleu van Loghum

مصطلحات موضوعية: Hemorrhage/chemically induced, Heparin, Low-Molecular-Weight/adverse effects, Humans, Anticoagulants/adverse effects, Pulmonary Embolism/complications, Venous Thromboembolism/drug therapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::ad2279662cd4335f010ab4e309e276f9
https://cris.maastrichtuniversity.nl/en/publications/791089d0-63f4-4aed-bc9f-6c36dd1e4c69

المصدر: Nederlands Tijdschrift voor Geneeskunde. 166

مصطلحات موضوعية: Low-Molecular-Weight/adverse effects, Heparin, Hemorrhage/chemically induced, Humans, Anticoagulants/adverse effects, Pulmonary Embolism/complications, Venous Thromboembolism/drug therapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od________83::2116b4b817a8bd756e5eb57897ab3a79
https://cris.maastrichtuniversity.nl/en/publications/791089d0-63f4-4aed-bc9f-6c36dd1e4c69

المؤلفون: Ruben J Eck, Tessa Elling, Alex J Sutton, Jørn Wetterslev, Christian Gluud, Iwan C C van der Horst, Reinold O B Gans, Karina Meijer, Frederik Keus

المساهمون: Lifelong Learning, Education & Assessment Research Network (LEARN), Groningen Kidney Center (GKC), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)

المصدر: BMJ (Clinical research ed.), 378. BMJ PUBLISHING GROUP

مصطلحات موضوعية: Deep-vein thrombosis, Low-Molecular-Weight/adverse effects, Placebo-controlled trial, Network Meta-Analysis, Heparin, Low-Molecular-Weight/adverse effects, Hemorrhage, Medical patients, Spinal-cord-injury, Hemorrhage/chemically induced, Humans, Heparin/adverse effects, Randomized Controlled Trials as Topic, UNFRACTIONATED HEPARIN, Molecular-weight heparin, Heparin, Venous thromboembolic events, Double-blind, Thrombosis/drug therapy, Anticoagulants, Bayes Theorem, Thrombosis, General Medicine, Venous Thromboembolism, Heparin, Low-Molecular-Weight, Hospitals, LOW-DOSE HEPARIN, Acute ischemic-stroke, Anticoagulants/adverse effects, Venous Thromboembolism/drug therapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1721369fe7bd4aa3e1ca832b1433905
https://pubmed.ncbi.nlm.nih.gov/35788047

المؤلفون: Oestreicher, S., Bouchardy, J., Rutz, T., Monney, P., Pruvot, É., Le Bloa, M.

المصدر: Revue medicale suisse, vol. 18, no. 783, pp. 1057-1063

مصطلحات موضوعية: Adult, Anticoagulants/therapeutic use, Heart Defects, Congenital/chemically induced, Heart Defects, Congenital/complications, Heart Defects, Congenital/drug therapy, Humans, Morbidity, Venous Thromboembolism/drug therapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1900::6160baf170dfb32ed657b02c26736578
https://serval.unil.ch/resource/serval:BIB_1224D3719DB2.P001/REF.pdf

المؤلفون: Agnieszka, Kotalczyk, Yutao, Guo, Maria, Stefil, Yutang, Wang, Gregory Y H, Lip

المصدر: Kotalczyk, A, Guo, Y, Stefil, M, Wang, Y, Lip, G Y H & on behalf of the ChiOTEAF Registry Investigators 2022, ' Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy : A Report From the ChiOTEAF Registry ', Journal of the American Heart Association, vol. 11, no. 7, e024319 . https://doi.org/10.1161/JAHA.121.024319

مصطلحات موضوعية: Stroke/etiology, Male, China, Asia, multimorbidity, registry, Atrial Fibrillation, Humans, atrial fibrillation, Prospective Studies, Registries, China/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation/drug therapy, Anticoagulants, Multimorbidity, Venous Thromboembolism, Middle Aged, Stroke, Anticoagulants/therapeutic use, Critical Pathways, Polypharmacy, Quality of Life, Female, Cardiology and Cardiovascular Medicine, Venous Thromboembolism/drug therapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc62106c9b7f01af9e390759f116fd6
https://pubmed.ncbi.nlm.nih.gov/35377169